Pediatrics & Therapeutics
Open Access

International Conference and Exhibition on Pediatric Oncology and Clinical Pediatrics

August 11-13, 2016 Toronto, Canada

Scientific Tracks Abstracts

• Cell differentiation and differentiation therapy in neuroblastoma

  Liqin Du

  PDF HTML

• Tumor-derived CD200 inhibits the development of an anti-tumor response: Implications for immunotherapy

  Michael R Olin

  PDF HTML

• A custom gene panel for interrogating pediatric overgrowth disorders and tumor predisposition

  Elizabeth Algar

  PDF HTML

• Autoimmunity and childhood cancers

  Nalini Kant Pati

  PDF HTML

• Inflammatory myofibroblastic tumor in children

  Ibtisam H Al-Shuaili

  PDF HTML

• Improvement of karyomegalic interstitial nephritis three years after ifosfamide and cisplatin therapy by corticosteroid

  Tomokazu Matsuura

  PDF HTML

• Detection of occult hepatitis-B virus infection among frequently blood transfused children

  Gehan Lotfy Abdel Hakeem, Salah Mahmoud Saleh, Sayed Fekry Abdel Wahab, Hend Mohamed Abdel ghany and Walaa Ahmed Abo El Hassan

  PDF HTML

• Metabonomic principles, applications in the pediatric field and epidemiology

  Marilyn Duquesne

  PDF HTML

• Blood stream infections during induction chemotherapy in children with acute myeloid leukemia -Changing spectrum in developing countries

  Divya Subburaj, Sreejith R, Ramya U and Revathi Raj

  PDF HTML

• Effect of Phoenix dactylifera palm date (Ajwa) on infection, hospitalization and mortality among pediatric cancer patients at single medical institute in Saudi Arabia

  Soad K Al Jaouni, Abear Hussein, Nora Alghamdi, Dalia Ezzat, Steve Harakeh, Nahla Khamis Ibrahim, Rajaa Raddadi and Shaker Mousa

  PDF HTML

• CHIC (Computational Horizons in Cancer) - Perspective from the clinical side

  Norbert Graf

  PDF HTML

• Computational Horizons in Cancer (CHIC): Developing meta- and hyper-multiscale models and repositories for in-silico oncology - Strategies, systems and results

  Georgios Stamatakos, D Dionysiou, R Bohle, S Gool, L Solie, F Dong, N McFarlane, M Viceconti, D Tartarini, K Marias, V Sakkalis, N Forgo, I Lishchuk, R Radhakrishnan, A Ghosh, H Byrne, J Grogan, C Guiot0, I Stura, P Buechler, M Reyes, E Neri, A Bucur, B de Bono, S Alexander, G Erbacci, D Testi,

  PDF HTML

• The law and in-silico health technology: Help or hindrance?

  Marc Stauch

  PDF HTML

• In silico oncology- Computational horizons in cancer systems biology and multi-scale cancer modeling

  Ravi Radhakrishnan

  PDF HTML

• CHIC-CDR: A repository for managing multi-modality clinical data and its application to in-silico oncology

  Daniel Abler

  PDF HTML

• Integrating CHIC technologies into a clinical research application framework (CRAF) for cancer modeling

  Kostas Marias

  PDF HTML

• PARP1 inhibition sensitizes Ewing sarcoma cells to DNA damage

  Raushan Kurmasheva

  PDF HTML

• Defining the risk factors of cardio-metabolic risk in survivors of childhood brain tumors

  M Constantine Samaan

  PDF HTML

• Novel AAV phage-targeted gene therapy for targeting chemoresistant childhood brain tumors

  Mariam Albahrani, Paladd Asavarut, Keittisak Suwan and Amin Hajitou

  PDF HTML

• New age for pediatric oncology

  Annick Beaugrand

  PDF HTML

• Expanding spectrum of Parvovirus B19 in pediatric infections: What is more than fifth s disease

  Janak Kishore

  PDF HTML

• Syndromatic osteosarcoma, does it carry a poor prognosis? King Hussein Cancer Centre experience

  Abdulqader Al-Hebshi

  PDF HTML

• Pediatric non-Hodgkin Lymphoma: A retrospective 7-year experience in children and adolescents with non-Hodgkin lymphoma treated in King Fahad Medical City (KFMC)

  Nahla Ali Mobark

  PDF HTML

• Individualized treatment with an optimal risk-benefit in children using pharmacokinetic-pharmacodynamic modeling in pediatric diseases and solid tumors

  Imke H Bartelink, Janel R Long-Boyle, Rada M Savic, Jaap Jan Boelens, Brendan Prideaux, Hilde Rosing, Leslie Floren, Denise Wolf, Laura van ‘t Veer and Pamela Munster

  PDF HTML